Cargando…

EGFR targeted therapy in lung cancer; an evolving story

Specific oncogenes with driver mutations, such as the Epidermal Growth Factor Receptor (EGFR 1) gene can lead to non-small-cell lung cancer formation. Identification of these oncogenes, their driver mutations and downstream effects allow the targeting of these pathways by drugs. Such personalised th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bartholomew, C., Eastlake, L., Dunn, P., Yiannakis, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302182/ https://www.ncbi.nlm.nih.gov/pubmed/28217439 http://dx.doi.org/10.1016/j.rmcr.2017.01.016

Ejemplares similares

Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept
por: Dragovich, Tomislav, et al.
Publicado: (2009)

COVID-19 coagulopathy: an evolving story
por: The Lancet Haematology
Publicado: (2020)

The Evolving Story of Multifactorial Chylomicronemia Syndrome
por: Paquette, Martine, et al.
Publicado: (2022)

Diagnosis of COVID-19 in children: the story evolves
por: Harwood, R., et al.
Publicado: (2020)

The Evolving Story in the Genetic Analysis for Heart Failure
por: Miyazawa, Kazuo, et al.
Publicado: (2021)

The evolving story of AtzT, a periplasmic binding protein
por: Dennis, Matthew L., et al.
Publicado: (2019)

Pharmacogenomics of EGFR-targeted therapies in non–small cell lung cancer: EGFR and beyond
por: Delaney, Christopher, et al.
Publicado: (2015)

Host-Parasite Relationship in Cystic Echinococcosis: An Evolving Story
por: Siracusano, Alessandra, et al.
Publicado: (2012)

The evolving story of orexin biology: the hits keep coming
por: Samson, Willis K
Publicado: (2009)

EGFR Mutations in Indian Lung Cancer Patients: Clinical Correlation and Outcome to EGFR Targeted Therapy
por: Noronha, Vanita, et al.
Publicado: (2013)

Emerging Roles of MicroRNAs in EGFR-Targeted Therapies for Lung Cancer
por: Han, Fei, et al.
Publicado: (2015)

The default network dominates neural responses to evolving movie stories
por: Yang, Enning, et al.
Publicado: (2023)

The evolving story of medical emergency teams in quality improvement
por: Amaral, André Carlos Kajdacsy-Balla, et al.
Publicado: (2009)

An Overview of the Genetics of ABCA4 Retinopathies, an Evolving Story
por: Al-Khuzaei, Saoud, et al.
Publicado: (2021)

EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation
por: Antonicelli, Alberto, et al.
Publicado: (2013)

Therapies in Cervical Cancer—Editorial
por: Naik, Raj, et al.
Publicado: (2023)

DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma
por: González, Iván A., et al.
Publicado: (2021)

Prader–Willi syndrome and autism spectrum disorders: an evolving story
por: Dykens, Elisabeth M., et al.
Publicado: (2011)

The evolving story of apolipoprotein L1 nephropathy: the end of the beginning
por: Daneshpajouhnejad, Parnaz, et al.
Publicado: (2022)

Activation of the AXL Kinase Causes Resistance to EGFR-Targeted Therapy in Lung Cancer
por: Zhang, Zhenfeng, et al.
Publicado: (2012)

Type I Interferons and Cancer: An Evolving Story Demanding Novel Clinical Applications
por: Aricò, Eleonora, et al.
Publicado: (2019)

Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer
por: Zhang, Zhe, et al.
Publicado: (2019)

MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer
por: Wang, Qiming, et al.
Publicado: (2019)

Inhaled β(2)-agonists in asthma management: an evolving story
por: Silva, Diana, et al.
Publicado: (2016)

The evolving story of Borrelia burgdorferi sensu lato transmission in Europe
por: Steinbrink, Antje, et al.
Publicado: (2022)

Photosynthesis and food security: the evolving story of C(4) rice
por: Furbank, Robert, et al.
Publicado: (2023)

ADAM 17 and Epithelial-to-Mesenchymal Transition: The Evolving Story and Its Link to Fibrosis and Cancer
por: Sisto, Margherita, et al.
Publicado: (2021)

Targeted Therapies in Non-Small Cell Lung Cancer—Beyond EGFR and ALK
por: Rothschild, Sacha I.
Publicado: (2015)

Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancer
por: Magios, Nikolaus, et al.
Publicado: (2021)

The Evolving Story of Autoantibodies in Pemphigus Vulgaris: Development of the “Super Compensation Hypothesis”
por: Sinha, Animesh A., et al.
Publicado: (2018)

Bench to Bedside and Back: The Evolving Story of Alpha-1 Antitrypsin Deficiency
por: Chapman, Kenneth R.
Publicado: (2020)

Effect of hydrothorax EGFR gene mutation and EGFR-TKI targeted therapy on advanced non-small cell lung cancer patients
por: ZHOU, BO, et al.
Publicado: (2016)

Dysregulation of Acetylation Enzymes in Animal Models of Psychostimulant use Disorders: Evolving Stories
por: Cadet, Jean Lud
Publicado: (2016)

Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer
por: Crintea, Andreea, et al.
Publicado: (2023)

Evolving targets for lipid-modifying therapy
por: Do, Rose Q, et al.
Publicado: (2014)

Targeting the tyrosine kinase inhibitor-resistant mutant EGFR pathway in lung cancer without targeting EGFR?
por: De Greve, Jacques, et al.
Publicado: (2020)

EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab
por: Reade, Chad A, et al.
Publicado: (2009)

Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies
por: Khaddour, Karam, et al.
Publicado: (2021)

EGFR endocytosis is a novel therapeutic target in lung cancer with wild-type EGFR
por: Jo, Ukhyun, et al.
Publicado: (2014)

Mechanisms of resistance to EGFR-targeted drugs: lung cancer
por: Morgillo, Floriana, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_341jdojfnuflg6biv6jq1of8vl